Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology ...Middle East

SEONGNAM, South Korea and AURORA, Colo., March 26, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres's Lab at the...

Hence then, the article about bridge biotherapeutics announces a research collaboration with the university of colorado school of medicine to explore potential of bbt 877 for immuno oncology was published today ( Wednesday 27/03/2024 - 01:10 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology )

Also on site :

• Belgium corrects US on ‘peace board’ claim
• Why is South Africa upset about Iran joining BRICS naval drills?
• Numbrix 9 - January 23